Results 11 to 20 of about 136,887 (323)

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Journal of the American College of Cardiology, 2018
Syed Mahmood, Michael G. Fradley, Justine V. Cohen, Anju Nohria, Kerry L. Reynolds, Lucie Heinzerling, Ryan J. Sullivan, Rongras Damrongwatanasuk, Carol L. Chen, Dipti Gupta, Michael Constantin Kirchberger, Magid Awadalla, Malek Hassan, Javid J. Moslehi, Sachin Shah, Sarju Ganatra, Paaladinesh Thavendiranathan, Donald P. Lawrence, John D. Groarke, Tomas G. Neilan   +19 more
openalex   +3 more sources

Exploring Pembrolizumab‐Induced IM3OS in a Patient With Bladder Cancer [PDF]

Pharmacology Research &Perspectives, Volume 14, Issue 1, February 2026.
ABSTRACT Pembrolizumab, an immune checkpoint inhibitor (ICI), has transformed cancer treatment across various malignancies, including metastatic urothelial cancer. As the use of pembrolizumab becomes increasingly widespread, understanding its potential adverse effects is essential.
Ching‐Cheng Chan, Ming‐Jen Lee, Jian Su, Jen‐Jen Su   +3 more
wiley   +2 more sources

Myocarditis [PDF]

Progress in Cardiovascular Diseases, 2010
Abstract Myocarditis is defined histologically as inflammation of the myocardium associated with injury to cardiac myocytes. Common viral infections are the most frequent cause of myocarditis, but other pathogens, hypersensitivity reactions, and systemic and autoimmune diseases should be considered and excluded during the initial ...
Lori A, Blauwet, Leslie T, Cooper
openaire   +4 more sources

Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies

JACC: Basic to Translational Science, 2023
Summary: The authors present a clinical report focused on the overlap between myocarditis and genetic cardiomyopathies of the dilated and arrhythmogenic spectrum.
Giovanni Peretto, MD, Giacomo De Luca, MD, Andrea Villatore, MD, Chiara Di Resta, PHD, Simone Sala, MD, Anna Palmisano, MD, PHD, Davide Vignale, MD, Corrado Campochiaro, MD, Davide Lazzeroni, MD, Monica De Gaspari, MD, Stefania Rizzo, MD, Elena Busnardo, MD, Paola Ferro, MD, Luigi Gianolli, MD, Cristina Basso, MD, PHD, Lorenzo Dagna, MD, Antonio Esposito, MD, Sara Benedetti, PHD, Paolo Della Bella, MD   +18 more
doaj   +1 more source

Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study

BMJ Medicine, 2023
Objective To investigate the clinical outcomes of myocarditis associated with mRNA vaccines against the SARS-CoV-2 virus compared with other types of myocarditis.Design Population based cohort study.Setting Nationwide register data from four Nordic ...
Øystein Karlstad, Lars Køber, Tommi Härkänen, Anders Husby, Jørgen Vinsløv Hansen, Anders Hviid, Rickard Ljung, Jesper Dahl, Hanne Løvdal Gulseth, Tiina Heliö, Nina Gunnes, Petteri Hovi, Nicklas Pihlström   +12 more
doaj   +1 more source

Comparison of Multisystem Inflammatory Syndrome in Children–Related Myocarditis, Classic Viral Myocarditis, and COVID‐19 Vaccine‐Related Myocarditis in Children

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Although rare, classic viral myocarditis in the pediatric population is a disease that carries significant morbidity and mortality. Since 2020, myocarditis has been a common component of multisystem inflammatory syndrome in children (MIS‐C ...
Trisha Patel, Michael Kelleman, Zachary West, Andrew Peter, Matthew Dove, Arene Butto, Matthew E. Oster   +6 more
doaj   +1 more source

Myocarditis With COVID-19 mRNA Vaccines

Circulation, 2021
Supplemental Digital Content is available in the text. Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males.
B. Bozkurt, I. Kamat, P. Hotez
semanticscholar   +1 more source

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

New England Journal of Medicine, 2021
Background Reports have suggested an association between the development of myocarditis and the receipt of messenger RNA (mRNA) vaccines against coronavirus disease 2019 (Covid-19), but the frequency and severity of myocarditis after vaccination have not
G. Witberg, N. Barda, S. Hoss, Ilan Richter, M. Wiessman, Y. Aviv, T. Grinberg, Oren Auster, Noa Dagan, R. Balicer, R. Kornowski   +10 more
semanticscholar   +1 more source

Revitalizing myocarditis treatment through gut microbiota modulation: unveiling a promising therapeutic avenue

Frontiers in Cellular and Infection Microbiology, 2023
Numerous studies have demonstrated that gut microbiota plays an important role in the development and treatment of different cardiovascular diseases, including hypertension, heart failure, myocardial infarction, arrhythmia, and atherosclerosis ...
Jingyue Wang, Jingyue Wang, Xianfeng Zhang, Xinyu Yang, Xinyu Yang, Hang Yu, Mengmeng Bu, Jie Fu, Zhengwei Zhang, Hui Xu, Jiachun Hu, Jinyue Lu, Haojian Zhang, Zhao Zhai, Wei Yang, Xiaodan Wu, Yan Wang, Qian Tong   +17 more
doaj   +1 more source

Myocarditis [PDF]

Circulation Research, 2016
Viral myocarditis remains a prominent infectious-inflammatory disease for patients throughout the lifespan. The condition presents several challenges including varied modes of clinical presentation, a range of timepoints when patients come to attention, a diversity of approaches to diagnosis, a spectrum of clinical courses, and unsettled perspectives ...
Gabriel, Fung, Honglin, Luo, Ye, Qiu, Decheng, Yang, Bruce, McManus   +4 more
openaire   +2 more sources